Market Size of Glycomics Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 13.90 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Glycomics Market Analysis
The glycomics market is expected to register a CAGR of 13.9% during the forecast period with the increasing research and development activities about glycomes and emerging technology for analysis of glycans and proteomes. Glycans, generally present on the cell surface, plays a very crucial role in the body system. They are responsible for many hereditary diseases and has a vital role in cancer development. Erythropoietin is a biological product used in anti-viral therapy and has three N-glycans and one O-glycan chain. Furthermore, in 2017, Sciex launched 'Fast Glycan Labelling and Analysis Kit.' It saves time and effort for sample preparation, mostly used in the quantitative estimation of N-glycan. Hence, these factors are expected to drive the glycomics market growth. But the high cost of products related to glycomes may obstruct the glycomes market growth.
Glycomics Industry Segmentation
As per the scope of the report, Glycomics is the study of glycomes, a sugar chain found in organisms either as a free chain or as a complex molecule. Glycomics is a subset of the field of glycobiology that aims to identify the structure and function of the complete set of glycans (the glycome) produced in a given cell or organism and identify all the genes that encode glycoproteins. Glycomics market is segmented by product type, applications, and geography. Instruments such as HPLC, Mass spectroscopy microarrays along with the reagents used in the glycomic analysis are being tracked in the report.
| By Product Type | |
| Instruments | |
| Reagents and Kits | |
| Enzymes |
| By Application | |
| Drug Development | |
| Diagnostics | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| Rest of the World |
Glycomics Market Size Summary
The glycomics market is poised for significant growth, driven by advancements in research and technology focused on glycans and proteomes. Glycans, which are crucial components on cell surfaces, play a pivotal role in various biological processes, including the development of hereditary diseases and cancer. The market is further propelled by innovations such as Sciex's 'Fast Glycan Labelling and Analysis Kit,' which streamlines the quantitative estimation of N-glycan, enhancing research efficiency. Despite the high costs associated with glycome-related products posing a challenge, the increasing demand for drug development and vaccine production, where glycans are integral, is expected to sustain market expansion. The application of glycans in medical treatments, such as hyaluronan in osteoarthritis and post-surgical wound care, underscores their importance in the pharmaceutical industry.
North America is anticipated to lead the glycomics market, supported by robust research and development activities and substantial government funding. Initiatives like the National Institute of Health's investment in glycoscience research highlight the region's commitment to advancing this field. The market is characterized by fragmentation, with major players like ThermoFisher Scientific Inc., Agilent Technologies Inc., and Merck KGaA actively engaging in strategic expansions, such as Agilent's acquisition of ProZyme, Inc. These companies are at the forefront of developing glycome products, contributing to the market's dynamic growth trajectory. The pharmaceutical industry's significant investment in research and development further bolsters the market's prospects, particularly in North America.
Glycomics Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Research and Development Activities in Glycomics
-
1.2.2 Technological Advancements in Products
-
-
1.3 Market Restraints
-
1.3.1 Complexity of Glycomics Coupled With The High Cost Involved in the Process
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product Type
-
2.1.1 Instruments
-
2.1.2 Reagents and Kits
-
2.1.3 Enzymes
-
-
2.2 By Application
-
2.2.1 Drug Development
-
2.2.2 Diagnostics
-
2.2.3 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Rest of the World
-
-
Glycomics Market Size FAQs
What is the current Glycomics Market size?
The Glycomics Market is projected to register a CAGR of 13.90% during the forecast period (2024-2029)
Who are the key players in Glycomics Market?
ThermoFisher Scientific Inc. - , Merck KGaA, New England Biolabs, Inc., Agilent Technologies, Inc. and Takara Bio Inc. are the major companies operating in the Glycomics Market.
